_:n2ccf5083faaf4158a23b53d614b90c77xb0
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/NewsArticle>
<http://finance.sananselmo.com/camedia.sananselmo/article/newsfile-2023-8-7-humanigen-announces-first-participant-dosed-in-rating-trial-of-lenzilumab-for-early-treatment-of-acute-graft-versus-host-disease-following-allogeneic-stem-cell-transplantation>